Recombinant human C1 esterase inhibitor for hereditary angio-oedema

Affiliations

¹ Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm D-89075 Germany. Electronic address: jens.greve@uniklinik-ulm.de.
² Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm D-89075 Germany.

Comment

Jens Greve et al. Lancet. 2017.

. 2017 Sep 30;390(10102):1566-1567.

doi: 10.1016/S0140-6736(17)31966-9. Epub 2017 Jul 25.

¹ Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm D-89075 Germany. Electronic address: jens.greve@uniklinik-ulm.de.
² Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm D-89075 Germany.

No abstract available

Comment on

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.
Riedl MA, Grivcheva-Panovska V, Moldovan D, Baker J, Yang WH, Giannetti BM, Reshef A, Andrejevic S, Lockey RF, Hakl R, Kivity S, Harper JR, Relan A, Cicardi M. Riedl MA, et al. Lancet. 2017 Sep 30;390(10102):1595-1602. doi: 10.1016/S0140-6736(17)31963-3. Epub 2017 Jul 25. Lancet. 2017. PMID: 28754491 Clinical Trial.